OBJECTIVE: We conducted a cross-sectional study to describe the prevalence and correlates of type-specific human papillomavirus (HPV) DNA in the oral cavities of persons with Fanconi anemia. MATERIALS AND METHODS: Oral swabs were collected from 67 participants with Fanconi anemia and tested for 27 HPV genotypes using polymerase chain reaction-based methods. RESULTS: Participants were a mean of 18.6 (standard deviation, 10.0) years of age (range 4-47 years). The prevalence of oral HPV infection was 7.5%, and the prevalence of high-risk HPV infection was 6.0%. HPV type 16 was not detected in any samples. Prevalence was higher in adults than in children (13.3% vs 2.7% in those ≥18 vs <18 years of age). Among adults, prevalence was higher in males than in females (25.0% vs 9.1%, respectively). CONCLUSIONS: Prevalence of oral HPV infection in persons with Fanconi anemia was comparable to estimates from other studies in the general population. However, in contrast to previous studies, we did not identify HPV type 16 (the type found in most HPV-related head and neck cancers) in any participants.
OBJECTIVE: We conducted a cross-sectional study to describe the prevalence and correlates of type-specific human papillomavirus (HPV) DNA in the oral cavities of persons with Fanconi anemia. MATERIALS AND METHODS: Oral swabs were collected from 67 participants with Fanconi anemia and tested for 27 HPV genotypes using polymerase chain reaction-based methods. RESULTS:Participants were a mean of 18.6 (standard deviation, 10.0) years of age (range 4-47 years). The prevalence of oral HPV infection was 7.5%, and the prevalence of high-risk HPV infection was 6.0%. HPV type 16 was not detected in any samples. Prevalence was higher in adults than in children (13.3% vs 2.7% in those ≥18 vs <18 years of age). Among adults, prevalence was higher in males than in females (25.0% vs 9.1%, respectively). CONCLUSIONS: Prevalence of oral HPV infection in persons with Fanconi anemia was comparable to estimates from other studies in the general population. However, in contrast to previous studies, we did not identify HPV type 16 (the type found in most HPV-related head and neck cancers) in any participants.
Authors: Blanche P Alter; Neelam Giri; Sharon A Savage; June A Peters; Jennifer T Loud; Lisa Leathwood; Ann G Carr; Mark H Greene; Philip S Rosenberg Journal: Br J Haematol Date: 2010-04-30 Impact factor: 6.998
Authors: Maura L Gillison; Tatevik Broutian; Robert K L Pickard; Zhen-you Tong; Weihong Xiao; Lisa Kahle; Barry I Graubard; Anil K Chaturvedi Journal: JAMA Date: 2012-01-26 Impact factor: 56.272
Authors: Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison Journal: J Clin Oncol Date: 2011-10-03 Impact factor: 44.544
Authors: Kasiani C Myers; Jack J Bleesing; Stella M Davies; Xue Zhang; Lisa J Martin; Robin Mueller; Richard E Harris; Alexandra H Filipovich; Melinda B Kovacic; Susanne I Wells; Parinda A Mehta Journal: Br J Haematol Date: 2011-05-04 Impact factor: 6.998
Authors: M R de Araujo; I R F Rubira-Bullen; C F Santos; T J Dionísio; C M S Bonfim; L De Marco; A Gillio-Tos; F Merletti Journal: Oral Dis Date: 2011-02-18 Impact factor: 3.511
Authors: Aimée R Kreimer; Rohini K Bhatia; Andrea L Messeguer; Paula González; Rolando Herrero; Anna R Giuliano Journal: Sex Transm Dis Date: 2010-06 Impact factor: 2.830
Authors: Jay H Lubin; Mark Purdue; Karl Kelsey; Zuo-Feng Zhang; Debbie Winn; Qingyi Wei; Renato Talamini; Neonilia Szeszenia-Dabrowska; Erich M Sturgis; Elaine Smith; Oxana Shangina; Stephen M Schwartz; Peter Rudnai; Jose Eluf Neto; Joshua Muscat; Hal Morgenstern; Ana Menezes; Elena Matos; Ioan Nicolae Mates; Jolanta Lissowska; Fabio Levi; Philip Lazarus; Carlo La Vecchia; Sergio Koifman; Rolando Herrero; Silvia Franceschi; Victor Wünsch-Filho; Leticia Fernandez; Eleonora Fabianova; Alexander W Daudt; Luigino Dal Maso; Maria Paula Curado; Chu Chen; Xavier Castellsague; Paul Brennan; Paolo Boffetta; Mia Hashibe; Richard B Hayes Journal: Am J Epidemiol Date: 2009-09-10 Impact factor: 4.897
Authors: Sharon L Sauter; Susanne I Wells; Xue Zhang; Elizabeth E Hoskins; Stella M Davies; Kasiani C Myers; Robin Mueller; Gitika Panicker; Elizabeth R Unger; Umasundari Sivaprasad; Darron R Brown; Parinda A Mehta; Melinda Butsch Kovacic Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-03-25 Impact factor: 4.254
Authors: Ruby Khoury; Sharon Sauter; Melinda Butsch Kovacic; Adam S Nelson; Kasiani C Myers; Parinda A Mehta; Stella M Davies; Susanne I Wells Journal: Viruses Date: 2018-01-20 Impact factor: 5.048
Authors: Tuna Toptan; Marion G Brusadelli; Brian Turpin; David P Witte; Jordi Surrallés; Eunike Velleuer; Martin Schramm; Ralf Dietrich; Ruud H Brakenhoff; Patrick S Moore; Yuan Chang; Susanne I Wells Journal: PLoS One Date: 2018-12-27 Impact factor: 3.240
Authors: Tafadzwa Chihanga; Sara Vicente-Muñoz; Sonya Ruiz-Torres; Bidisha Pal; Mathieu Sertorio; Paul R Andreassen; Ruby Khoury; Parinda Mehta; Stella M Davies; Andrew N Lane; Lindsey E Romick-Rosendale; Susanne I Wells Journal: Cancers (Basel) Date: 2022-04-18 Impact factor: 6.575